obesity drug news today glp-1 september 2025 Weight-Loss Demonstration Begins July 2026 How Supply and Demand for
Description
doi: 10.2147/OTT 72 Bjerre KnudsenLMadsenLWAndersenSAlmholtKde BoerASDruckerDJet al
Medication trials for hyperphagia and food-related behaviors in Prader-Willi syndrome
The future of NAFLD treatment seems exciting and challenging and has the potential to include more personalized and targeted therapeutic approaches, while issues concerning their safety must be thoroughly recorded and appropriately evaluated [42, 43, 138, 144146].
Glucagon-like peptide-1 receptor agonists during pregnancy and lactation
Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Thermodynamic scale of -amino acid residue propensities for an -helix-like conformation
